FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2179022218> ?p ?o ?g. }

• W2179022218 endingPage "314" @default.
• W2179022218 startingPage "312" @default.
• W2179022218 abstract "The four major comments of muscle wasting disease are cachexia, sarcopenia, malnutrition and congenital.1, 2 Of these, the most common is sarcopenia.3-7 Since sarcopenia is a clinical situation which causes various adverse outcomes, including immobility, falls, disability and death in older people 8-13, the importance of recognizing and treating sarcopenia has been recognized by providing an ICD-10 code for sarcopenia. Since the publication of the European Working Group consensus paper on sarcopenia in older persons,14 a number of other definitions have been published.15-18 All these definitions have stressed that sarcopenia should be defined as a loss of muscle function associated with a loss of muscle mass.19-21 This change in definition was necessitated by the recognition that muscle quality and, therefore, muscle performance were not directly related to muscle mass.22 Two factors appear to be responsible for this, viz the fact that sarcopenia is a neuromuscular junction disease23, 24 and the infiltration of fat into muscle during the ageing process.25, 26 The measurement of muscle mass has classically been done by anthropomorphic measures or dual energy x-ray absorptiometry.27 However, ultrasound, bioelectrical impedance, computed tomography, and magnetic resonance imaging have also been used. Goodman et al.,28 utilizing the NHANES data, suggested that Body Mass Index (BMI) is a reasonable proxy as a skeletal muscle index. Yu et al.29 utilized equations using BMI, weight, and age and showed that these are excellent predictive equations for skeletal muscle mass. A recent review of methods to assess sarcopenia found that for epidemiological studies, bioelectrical impedance for measuring muscle mass coupled with either gait speed or grip dynamometry were the most simple methods to identify sarcopenia based on the modern definitions.30 Recently it was shown that the questions used in the FRAX as part of diagnosis fracture risk had excellent specificity and sensitivity in recognizing risk when used without measuring bone mineral density.31 This raised the possibility that persons with sarcopenia could be identified by a simple questionnaire. This led to the development of SARC-F as a simple questionnaire to rapidly diagnose sarcopenia (Table 1).32, 33 Cao et al.34 showed that SARC-F was associated with poor physical performance, grip strength, and hospitalization in the previous 2 years. Woo et al.35 showed that SARC-F has excellent specificity when identifying persons with sarcopenia diagnosed by either the European or Asian working group definitions. Further, the Hong Kong group showed that SARC-F had similar predictive value for walking speed, physical limitation, hospitalization, and mortality as the Foundation of the National Institutes of Health and four other consensus definitions for sarcopenia.36 Woo et al.37 then showed that it could be used prospectively to successfully screen for sarcopenia. Malmstrom et al.38 showed that the SARC-F was a valid tool in three populations viz the Baltimore Longitudinal study, the African American Cohort in St. Louis, and the NHANES population. Sarcopenia is a major component of physical frailty in older persons.39 The simple FRAIL score has been shown to be a valid measure for detecting frailty.40-42 Between 40 and 70% of persons who are frail are also sarcopenic.37, 43 Thus, it makes sense to screen for both frailty and sarcopenia in older individuals as is done in the Rapid Geriatric Assessment (RGA).44 In addition, middle aged persons with diabetes mellitus,45-47 chronic obstructive pulmonary disease,48, 49 and hip fracture50, 51 are at high risk of having sarcopenia and therefore should be screened. The accumulating evidence shows that sarcopenia could be alleviated by resistance exercise,52-55 leucine enriched essential amino acids,56-58 and vitamin D.59 New promising drugs for sarcopenia are in development. 59 Given that we have a successful treatment which enhances outcome for sarcopenia, it would seem that utilizing the SARC-F, which takes under 15 s to do, to screen older persons and those with specific diseases with a high propensity to become sarcopenic, is an imminently sensible approach to prevent disability and hospitalization in older persons. The importance of recognizing and treating sarcopenia has been recognized by providing an ICD-10 code for sarcopenia. This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number U1QHP28716 Geriatrics Workforce Enhancement Program for $832 079. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS, or the U.S. Government. The authors certify that they comply with the ethical guidelines for authorship and publishing of the Journal of Cachexia, Sarcopenia, and Muscle (von Haehling S, Morley JE, Coats AJS, Anker SD). Ethical guidelines for authorship and publishing in the Journal of Cachexia, Sarcopenia, and Muscle. J Cachexia Sarcopenia Muscle. 2010;1:7–8. None declared." @default.
• W2179022218 created "2016-06-24" @default.
• W2179022218 creator A5006935353 @default.
• W2179022218 creator A5065158388 @default.
• W2179022218 date "2015-11-18" @default.
• W2179022218 modified "2023-09-27" @default.
• W2179022218 title "Rapid screening for sarcopenia" @default.
• W2179022218 cites W1516235509 @default.
• W2179022218 cites W1864182830 @default.
• W2179022218 cites W1965927192 @default.
• W2179022218 cites W1969409926 @default.
• W2179022218 cites W1977246008 @default.
• W2179022218 cites W1978908191 @default.
• W2179022218 cites W1979563615 @default.
• W2179022218 cites W1986351373 @default.
• W2179022218 cites W1988574927 @default.
• W2179022218 cites W1994876744 @default.
• W2179022218 cites W1996780734 @default.
• W2179022218 cites W1996959689 @default.
• W2179022218 cites W2005848242 @default.
• W2179022218 cites W2006321209 @default.
• W2179022218 cites W2011108340 @default.
• W2179022218 cites W2017033932 @default.
• W2179022218 cites W2017754801 @default.
• W2179022218 cites W2021653273 @default.
• W2179022218 cites W2022173684 @default.
• W2179022218 cites W2024967559 @default.
• W2179022218 cites W2029932732 @default.
• W2179022218 cites W2031320996 @default.
• W2179022218 cites W2037605387 @default.
• W2179022218 cites W2037938770 @default.
• W2179022218 cites W2039735127 @default.
• W2179022218 cites W2041135039 @default.
• W2179022218 cites W2043302415 @default.
• W2179022218 cites W2048798480 @default.
• W2179022218 cites W2050506657 @default.
• W2179022218 cites W2052857230 @default.
• W2179022218 cites W2068515995 @default.
• W2179022218 cites W2072110784 @default.
• W2179022218 cites W2075975941 @default.
• W2179022218 cites W2077411129 @default.
• W2179022218 cites W2082141482 @default.
• W2179022218 cites W2091001442 @default.
• W2179022218 cites W2096856754 @default.
• W2179022218 cites W2102902846 @default.
• W2179022218 cites W2103603960 @default.
• W2179022218 cites W2108985797 @default.
• W2179022218 cites W2109789037 @default.
• W2179022218 cites W2109826354 @default.
• W2179022218 cites W2110630734 @default.
• W2179022218 cites W2115150337 @default.
• W2179022218 cites W2117743214 @default.
• W2179022218 cites W2125916200 @default.
• W2179022218 cites W2126607801 @default.
• W2179022218 cites W2127721584 @default.
• W2179022218 cites W2132273917 @default.
• W2179022218 cites W2132950784 @default.
• W2179022218 cites W2145338083 @default.
• W2179022218 cites W2148366507 @default.
• W2179022218 cites W2155173050 @default.
• W2179022218 cites W2162998896 @default.
• W2179022218 cites W2166636130 @default.
• W2179022218 cites W2170611892 @default.
• W2179022218 cites W2170792707 @default.
• W2179022218 cites W819537267 @default.
• W2179022218 doi "https://doi.org/10.1002/jcsm.12079" @default.
• W2179022218 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4670738" @default.
• W2179022218 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26676168" @default.
• W2179022218 hasPublicationYear "2015" @default.
• W2179022218 type Work @default.
• W2179022218 sameAs 2179022218 @default.
• W2179022218 citedByCount "56" @default.
• W2179022218 countsByYear W21790222182016 @default.
• W2179022218 countsByYear W21790222182017 @default.
• W2179022218 countsByYear W21790222182018 @default.
• W2179022218 countsByYear W21790222182019 @default.
• W2179022218 countsByYear W21790222182020 @default.
• W2179022218 countsByYear W21790222182021 @default.
• W2179022218 countsByYear W21790222182022 @default.
• W2179022218 countsByYear W21790222182023 @default.
• W2179022218 crossrefType "journal-article" @default.
• W2179022218 hasAuthorship W2179022218A5006935353 @default.
• W2179022218 hasAuthorship W2179022218A5065158388 @default.
• W2179022218 hasBestOaLocation W21790222181 @default.
• W2179022218 hasConcept C121608353 @default.
• W2179022218 hasConcept C126322002 @default.
• W2179022218 hasConcept C126838900 @default.
• W2179022218 hasConcept C143409427 @default.
• W2179022218 hasConcept C2776214593 @default.
• W2179022218 hasConcept C2777704314 @default.
• W2179022218 hasConcept C2779764123 @default.
• W2179022218 hasConcept C2779959927 @default.
• W2179022218 hasConcept C2780221984 @default.
• W2179022218 hasConcept C2992343062 @default.
• W2179022218 hasConcept C33872192 @default.
• W2179022218 hasConcept C71924100 @default.
• W2179022218 hasConcept C99508421 @default.
• W2179022218 hasConceptScore W2179022218C121608353 @default.

• next